Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myeloproliferative Disorders × Exercise × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 203 Breast Neoplasms 110 Neoplasms 89 Prostatic Neoplasms 32 Fatigue 27 Obesity 22 Colorectal Neoplasms 20 Lung Neoplasms 15 Colonic Neoplasms 15 Polycystic Ovary Syndrome 13 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Lymphoma 9 Lymphedema 9 Hematologic Neoplasms 9 Multiple Myeloma 8 Brain Neoplasms 8 Weight Loss 7 Pancreatic Neoplasms 7 Insulin Resistance 7 Cardiotoxicity 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Overweight 5 Lymphoma, Follicular 5

Interventions

Cyclophosphamide 74 fludarabine phosphate 69 Peripheral Blood Stem Cell Transplantation 54 Mycophenolic Acid 46 Whole-Body Irradiation 45 Busulfan 45 Tacrolimus 44 Antilymphocyte Serum 39 fludarabine 37 Cyclosporine 36 Filgrastim 33 Cytarabine 29 Methotrexate 28 ruxolitinib 27 Melphalan 26 Radiotherapy 21 Etoposide 20 Azacitidine 19 Methylprednisolone 18 Sirolimus 14 Decitabine 14 Cord Blood Stem Cell Transplantation 14 Biopsy 14 Specimen Handling 13 Granulocyte Colony-Stimulating Factor 13 Flow Cytometry 13 thymoglobulin 12 venetoclax 11 Cyclosporins 11 Alemtuzumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07384039 2026-02-05

MPN-Exercise

Hannover Medical School

Phase NA Not yet recruiting

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡